Evidence map›Paper›PMID 36261158›Full record

ReviewEuropean respiratory review : an official journal of the European Respiratory Society2022

Respiratory viruses: their importance and lessons learned from COVID-19.

Catia Cilloniz, Carlos M Luna, Juan Carlos Hurtado, María Ángeles Marcos, Antoni Torres

Open access · diamondAbstract readReview
In one paragraph

Review in European respiratory review : an official journal of the European Respiratory Society, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 40 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
40citing papers in PubMed, 1 pooled it
8.7field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

40 citing papers in PubMed, 1 synthesis or guideline pooled it, 57 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Observational
  4. Review
  5. Article
  6. Article
  7. Article
  8. Type I interferons induced upon respiratory viral infection impair lung metastatic initiation.Proceedings of the National Academy of Sciences of the United States of America · 2026
    Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. βNature communications · 2025
    Article
  14. Article
  15. Article
  16. Scar wars: the viral menace.American journal of physiology. Lung cellular and molecular physiology · 2025
    Review
  17. Article
  18. Observational
  19. The next viral pandemic-where do we stand?Folia microbiologica · 2025
    Review
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

5 authors at 3 institutions in 3 countries.

Catia CillonizPneumology Dept, Respiratory Institute, Hospital Clinic of Barcelona - Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), University of Barcelona (UB), Barcelona, Spain catiacilloniz@yahoo.com.ORCID https://orcid.org/0000-0002-4646-9838
Carlos M LunaPneumology Division, Hospital of Clínicas, Faculty of Medicine, Universidad de Buenos Aires, Buenos Aires, Argentina.ORCID https://orcid.org/0000-0002-9288-096X
Juan Carlos HurtadoDept of Microbiology, Hospital Clinic, Universitat de Barcelona, ISGlobal, Barcelona, Spain.
María Ángeles MarcosDept of Microbiology, Hospital Clinic, Universitat de Barcelona, ISGlobal, Barcelona, Spain.
Antoni TorresPneumology Dept, Respiratory Institute, Hospital Clinic of Barcelona - Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), University of Barcelona (UB), Barcelona, Spain.ORCID https://orcid.org/0000-0002-8643-2167
Barcelona Institute for Global Health · ESCentro de Investigación Biomédica en Red de Enfermedades Respiratorias · ESUniversidad de Buenos Aires · AR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Respiratory virus infection can cause severe illnesses capable of inducing acute respiratory failure that can progress rapidly to acute respiratory distress syndrome (ARDS). ARDS is related to poor outcomes, especially in individuals with a higher risk of infection, such as the elderly and those with comorbidities,

Indexed as

COVID-19Respiratory Distress SyndromeVirusesAgedAntiviral AgentsBiomarkersHumansSARS-CoV-2Antiviral AgentsBiomarkers

Identifiers

PMID36261158
PMCPMC9724808
OpenAlexW4306780978

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.